- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
The association between chronic lymphocytic leukaemia and rheumatoid arthritis has been confirmed in some cases. Rheumatoid arthritis is a chronic autoimmune inflammatory disease characterized by erosive arthritis of the joints.
Chronic lymphocytic leukaemia is a clonal malignancy of lymphocytes, which is manifested by immunosuppression, bone marrow failure, and organ infiltration with neoplastic cells.
Showing all 7 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
09/2018 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
12/2018 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2019 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2019 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
12/2019 |
126,90 € |
||
CD20 |
Monoclonal Antibody |
MabThera® |
10 mg/mL |
– |
2 mg |
-80°C |
07/2021 |
126,90 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin